Results 31 to 40 of about 8,424 (263)

Tibial bypass salvage with eptifibatide in a patient with thrombocythemia [PDF]

Journal of Vascular Surgery Cases, 2015
Early graft failure is a complex and challenging clinical condition faced by vascular surgeons performing infrainguinal bypass surgery. This case describes a patient with undiagnosed thrombocytosis undergoing urgent open revascularization for critical limb ischemia.
John Byrne, Elisa Greco, Erik Yeo, Stuart A. McCluskey, Thomas F. Lindsay   +4 more
openalex   +4 more sources

Eptifibatide, an Older Therapeutic Peptide with New Indications: From Clinical Pharmacology to Everyday Clinical Practice

International Journal of Molecular Sciences, 2023
Therapeutic peptides are oligomers or short polymers of amino acids used for various medical purposes. Peptide-based treatments have evolved considerably due to new technologies, stimulating new research interests.
Gašper Tonin, Jasna Klen
semanticscholar   +1 more source

Efficacy and Safety of Abbreviated Eptifibatide Treatment in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention [PDF]

American Journal of Cardiology, 2020
Florian Fischer, Samriddhi Buxy Sinha, David J. Kurz, Franz R. Eberli, Oliver Senn, Rainer Zbinden, Ulrike Held, Matthias R. Meyer   +7 more
openalex   +2 more sources

Combined Approach to Eptifibatide and Thrombectomy in Acute Ischemic Stroke Because of Large Vessel Occlusion: A Matched-Control Analysis

Stroke, 2022
Background: In patients undergoing mechanical thrombectomy (MT), adjunctive antithrombotic might improve angiographic reperfusion, reduce the risk of distal emboli and reocclusion but possibly expose patients to a higher intracranial hemorrhage risk ...
G. Ma, Xuan Sun, Huiran Cheng, W. Burgin, W. Luo, W. Jia, Yajie Liu, Wenlong He, Xiaokun Geng, Liangfu Zhu, Xingyu Chen, Huaizhang Shi, Haowen Xu, Litong Zhang, Anxin Wang, D. Mo, N. Ma, F. Gao, Ligang Song, X. Huo, Yiming Deng, Lian Liu, G. Luo, Baixue Jia, X. Tong, Liping Liu, Zeguang Ren, Z. Miao   +27 more
semanticscholar   +1 more source

Application of eptifibatide injection in acute ischemic cerebrovascular disease [PDF]

Xin yixue, 2022
Objective To evaluate the treatment effectiveness and safety of eptifibatide injection in the treatment of acute ischemic cerebrovascular disease （ICVD）.
Mei Ni, Tian Liang
doaj   +1 more source

Eptifibatide use in ischemic stroke patients undergoing endovascular thrombectomy: A matched cohort analysis

Frontiers in Neurology, 2022
Introduction Small studies have suggested that eptifibatide (EPT) may be safe in acute ischemic stroke (AIS) following intravenous thrombolysis or during endovascular therapy (EVT) for large vessel occlusion (LVO).
Ameena Rana, Siyuan Yu, Savina Reid-Herrera, Scott Kamen, K. Hunter, H. Shaikh, T. Jovin, Olga R Thon, Parth Patel, J. Siegler, Jesse M. Thon   +10 more
semanticscholar   +1 more source

Results of a pilot clinical trial of the safety and efficacy of an original glycoprotein IIb/IIIa receptor inhibitor in acute coronary syndrome

Кардиоваскулярная терапия и профилактика, 2023
Aim. To study the safety and efficacy of Angipure in acute ST-segment elevation coronary syndrome (STE-ACS) and high-risk percutaneous transluminal coronary angioplasty (PTCA) compared with eptifibatide.Material and methods.
S. V. Lukyanov, Yu. F. Glukhov, E. V. T., B. M. Tankhilevich, D. A. Zateyshchikov, T. V. Khlevchuk, I. B. Bondareva   +6 more
doaj   +1 more source

Eptifibatide-Induced Severe Thrombocytopenia After ST-Elevation Myocardial Infarction (STEMI): A Case Report

Cureus, 2022
Eptifibatide is a platelet glycoprotein (GP) IIb/IIIa inhibitor that is used in certain cases of acute coronary syndrome, including those with high thrombus burden or with no-reflow.
Zaid Gheith, Areej Kilani, Tam Nguyen
semanticscholar   +1 more source

Treatment of progressive ischemic stroke with low‑dose eptifibatide: A retrospective case‑control study

Experimental and Therapeutic Medicine, 2022
Progressive ischemic stroke (PIS) is a therapeutic challenge in clinical practice. The present retrospective study aimed to investigate the safety and effectiveness of eptifibatide in the treatment of PIS.
Longfeng Luo, Jinsheng Lin, Ye Deng, Zhigang Li, Ying Yuan, Wen Zhang   +5 more
semanticscholar   +1 more source

Safety of Eptifibatide for Subcortical Stroke Progression [PDF]

Cerebrovascular Diseases, 2009
<i>Background:</i> There is no proven treatment for stroke progression in patients with subcortical infarcts. Eptifibatide, a glycoprotein IIb/IIIa inhibitor, might halt stroke progression by improving flow in the microcirculation. <i>Methods:</i> We conducted a retrospective analysis of patients with subcortical stroke who ...
James C. Grotta, Anitha T. Abraham, Hashem Shaltoni, Sheryl Martin-Schild, Andrew D Barreto, Hen Hallevi, Sean I Savitz, Sean I Savitz, Nicole R. Gonzales   +8 more
openaire   +3 more sources